178 related articles for article (PubMed ID: 21703465)
1. [Management of cutaneous lymphoma ].
Beylot-Barry M; Battistella M
Ann Dermatol Venereol; 2011 May; 138(5 Suppl 2):H13-8. PubMed ID: 21703465
[No Abstract] [Full Text] [Related]
2. Diffuse large cell non-Hodgkin's lymphoma, CD30+, T-cell phenotype.
Gruson LM; Latkowski JA
Dermatol Online J; 2005 Dec; 11(4):17. PubMed ID: 16403389
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous T cell lymphoma: update on treatment.
Wollina U
Int J Dermatol; 2012 Sep; 51(9):1019-36. PubMed ID: 22909354
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification.
Kong YY; Dai B; Kong JC; Zhou XY; Lu HF; Shen L; Du X; Shi DR
Am J Surg Pathol; 2008 Oct; 32(10):1495-502. PubMed ID: 18708940
[TBL] [Abstract][Full Text] [Related]
5. Proceedings of the Second International Symposium on Cutaneous T-cell Lymphoma. Chicago, Illinois, Oct. 13-17, 1993.
Herrmann JJ; Kuzel TM; Rosen ST; Roenigk HH
J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):819-22. PubMed ID: 7523465
[No Abstract] [Full Text] [Related]
6. Erythematous atrophic plaque in the inguinal fold.
Graves MS; Orr WB; Anand D; Davis LS
Cutis; 2016 May; 97(5):334;341;342. PubMed ID: 27274547
[No Abstract] [Full Text] [Related]
7. Long-term bexarotene monotherapy in large cell CD30+ pleomorphic T-cell lymphoma.
Aldaoud A
Dermatol Clin; 2008 Jan; 26 Suppl 1():15-7. PubMed ID: 18405181
[No Abstract] [Full Text] [Related]
8. Photoinactivated lymphocyte therapy of cutaneous T-cell lymphoma.
Heald P; Knobler R; LaRoche L
Dermatol Clin; 1994 Apr; 12(2):443-9. PubMed ID: 8045055
[TBL] [Abstract][Full Text] [Related]
9. The immunopathogenesis of cutaneous T-cell lymphoma.
Rook AH; Heald P
Hematol Oncol Clin North Am; 1995 Oct; 9(5):997-1010. PubMed ID: 8522492
[TBL] [Abstract][Full Text] [Related]
10. Graft-versus-lymphoma effect.
Richard C; Bermúdez A; Izu R
Br J Haematol; 2010 Apr; 149(2):166. PubMed ID: 20015300
[No Abstract] [Full Text] [Related]
11. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma.
Gormley RH; Hess SD; Anand D; Junkins-Hopkins J; Rook AH; Kim EJ
J Am Acad Dermatol; 2010 Feb; 62(2):300-7. PubMed ID: 19944484
[TBL] [Abstract][Full Text] [Related]
12. Localized cutaneous T cell lymphoma presenting as disfiguring facial lesions.
Kaliyadan F; Jayasree MG; Unni M; Neeraj S
Dermatol Online J; 2009 Nov; 15(11):14. PubMed ID: 19951650
[No Abstract] [Full Text] [Related]
13. Primary cutaneous Epstein-Barr virus-associated T-cell lymphoproliferative disorder-2 cases with unusual, prolonged clinical course.
Park S; Lee DY; Kim WS; Ko YH
Am J Dermatopathol; 2010 Dec; 32(8):832-6. PubMed ID: 20595887
[TBL] [Abstract][Full Text] [Related]
14. Treatment of cutaneous T-cell lymphoma: an update.
Young JW
J Am Osteopath Assoc; 1993 May; 93(5):591-8, 603. PubMed ID: 8314721
[TBL] [Abstract][Full Text] [Related]
15. A case of CD30+ nasal natural killer/T-cell lymphoma.
Ferenczi K; Summers P; Aubert P; Cooper B; Meyerson H; Cooper KD; Honda K
Am J Dermatopathol; 2008 Dec; 30(6):567-71. PubMed ID: 19033930
[TBL] [Abstract][Full Text] [Related]
16. [Therapy of cutaneous T-cell lymphomas].
Rappersberger K; Ortel B; Forstinger C; Wolff K
Wien Klin Wochenschr; 1994; 106(10):300-8. PubMed ID: 8053197
[TBL] [Abstract][Full Text] [Related]
17. Monitoring the decrease of circulating malignant T cells in cutaneous T-cell lymphoma during photopheresis and interferon therapy.
Ferenczi K; Yawalkar N; Jones D; Kupper TS
Arch Dermatol; 2003 Jul; 139(7):909-13. PubMed ID: 12873887
[TBL] [Abstract][Full Text] [Related]
18. Lymphomatoid papulosis and Ki-1 (CD30)-positive cutaneous large cell lymphomas.
Kaudewitz P; Burg G
Semin Diagn Pathol; 1991 May; 8(2):117-24. PubMed ID: 1651550
[No Abstract] [Full Text] [Related]
19. Pathobiology of CD30+ cutaneous T-cell lymphomas.
Kadin ME
J Cutan Pathol; 2006 Feb; 33 Suppl 1():10-7. PubMed ID: 16412208
[TBL] [Abstract][Full Text] [Related]
20. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]